logo
Reklaim Introduces Consumer Ownership Program -- A New Model for Shareholder Participation

Reklaim Introduces Consumer Ownership Program -- A New Model for Shareholder Participation

Cision Canada2 days ago

Canadians can now redeem points for MYID shares at no cost or dilution, bringing more visibility and retail investor interest to Reklaim
TORONTO, June 12, 2025 /CNW/ - Reklaim Ltd. (TSXV: MYID) (OTC: MYIDF) ("Reklaim" or the "Company"), a pioneer in consumer data privacy and monetization, today announced the official launch of Reklaim Invest, a first-of-its-kind program that allows Canadian users of the Reklaim platform to redeem their accumulated points for publicly traded shares in Reklaim (MYID) - offering a new way to invest in a public company using loyalty rewards. This initiative represents a broader strategic shift, one that turns engaged users into long-term shareholders, reduces reliance on paid acquisition, and deepens consumer alignment with the Company's mission.
Reklaim is the first company in Canada — and, to our knowledge, the first globally — to offer consumers the ability to convert loyalty points into equity in a publicly listed company.
Key Program Features
No dilution: All shares issued are offset 1:1 in a separate transaction via Reklaim's TSX-approved share buyback Normal Course Issuer Bid (NCIB)
Zero cost: Consumers pay nothing to participate, but must be a Reklaim member
Self-custody DRS: Shares issued via the Direct Registration System (DRS) — a secure, non-custodial shareholding method for direct retail investors
Regulatory compliance: Shares are subject to a mandatory four-month hold period
A New Model for Ownership: Reklaim Invest
Reklaim Invest functions similarly to a Dividend Reinvestment Plan (DRIP) — but instead of dividends, Reklaim users passively earn shares in Reklaim (MYID) by redeeming points earned through sharing their data with Fortune 500 brands and agencies. The program is currently available only to Canadian users and is free to participate.
The share redemption program has been operating in beta over the past six months, during which Reklaim completed multiple redemption cycles and integrated all required disclosures, regulatory agreements, and electronic signature flows directly within the Reklaim app. The current redemption window is now open and will close on July 1, 2025.
The Creation of a Public Market DAO
"With Reklaim Invest, we wanted our users and investors to be the same — giving them real equity, real ownership, and real say," said Neil Sweeney, CEO of Reklaim. "While others have tried this in crypto, we believe the public markets are already the best version of that idea. No tokens — just compliance, access, and real stock."
"This program shifts the narrative from selling your data to investing in you. It also lays the foundation for Reklaim to evolve into a broader fintech platform, with future offerings.
Strategic Value Creation
This program expands Reklaim's retail shareholder base, increases user engagement, and reinforces the brand as a privacy-first alternative to traditional data platforms. It introduces a new class of long-term, like-minded investors, many of whom are engaging with Reklaim for the first time. With this launch, the Reklaim user and the Reklaim investor become one and the same: a compounding force that deepens alignment, loyalty, and advocacy.
More Ways to Take Control: Reklaim Protect
Reklaim Invest builds on the momentum of Reklaim Protect, a new subscription-based privacy service launched two weeks ago that empowers users to reduce their data footprint across the internet. Protect scans data broker networks for personal information, facilitates opt-outs, and monitors the dark web for potential breaches, giving users more visibility and security over how their data is used.
Together, Reklaim Invest and Reklaim Protect represent a broader evolution of Reklaim's platform: giving consumers the tools to protect, monetize, or invest in their data on their own terms.
About Reklaim
Reklaim (TSXV: MYID, OTC: MYIDF) is a pioneer in consumer data privacy and compliant data monetization. Through its mobile app, Reklaim empowers users to take control of their personal data — choosing how it's used, who can access it, and how they benefit. Users can earn rewards, including shares in Reklaim (MYID), for participating in a transparent, privacy-first data economy.
For those looking to protect rather than monetize their data, Reklaim offers Reklaim Protect — a subscription service that reduces a user's digital footprint by removing their data from brokers and people-finder sites while actively monitoring the dark web for breaches.
To learn more, visit www.reklaimyours.com.
Meta description (max ~155 characters):
SOURCE Reklaim Ltd.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mogo Applies to Extend the Expiry Dates of Certain Warrants
Mogo Applies to Extend the Expiry Dates of Certain Warrants

National Post

time2 hours ago

  • National Post

Mogo Applies to Extend the Expiry Dates of Certain Warrants

Article content VANCOUVER, British Columbia — Mogo Inc. (NASDAQ:MOGO) (TSX:MOGO) ('Mogo' or the 'Company'), a digital wealth and payments business, today announced that it has applied to the Toronto Stock Exchange (the 'TSX') to extend the expiry date of 1,120,371 common share purchase warrants (the 'Warrants'). The Warrants were issued pursuant to the Company's US$27.5 million Registered Direct offering in December 2021 and are currently set to expire on June 13, 2025. The Warrants consist of 101,852 warrants with an exercise price of US$16.875 per common share and 1,018,519 warrants with an exercise price of US$14.10 per common share. Each Warrant entitles the holder thereof to acquire one common share of the Company and all other terms of the Warrants will remain the same. Article content The Company is seeking to extend the expiry date of the Warrants to June 13, 2026. No insiders of the Company hold any of the Warrants, directly or indirectly. Finalization of this extension is subject to the approval of the TSX and the warrantholders. If such approvals are obtained, this extension will be effective on the date that is ten business days from the date of this press release (the 'Effective Date'), and the Warrants cannot be exercised during the period from June 13, 2025 up to the Effective Date. Article content Article content Mogo Inc. Article content (NASDAQ:MOGO; TSX:MOGO) is a financial technology company with three distinct business lines: wealth, lending, and payments. Our mission is to provide consumers with innovative financial solutions that drive long-term financial health and success. We operate with a differentiated approach in each business, leveraging technology, behavioral science, and financial tools to create unique value propositions in our respective markets. Article content Our wealth and lending businesses are focused on the Canadian market, where we are the only subprime consumer lender that also offers a holistic wealth and investing solution. This unique integration is designed to help consumers transition from borrowing and debt to long-term wealth building. Separately, our payments business is operated through Carta Worldwide, a wholly owned subsidiary that provides modern card issuing and processing solutions, primarily in Europe. Article content Forward-Looking Statements Article content This news release may contain 'forward-looking statements' within the meaning of applicable securities legislation, including statements regarding the extension of the expiry date of the Warrants, including receipt of TSX and warrantholder approval. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at the time of preparation, are inherently subject to significant business, economic and competitive uncertainties and contingencies, and may prove to be incorrect. Forward-looking statements are typically identified by words such as 'may', 'will', 'could', 'would', 'anticipate', 'believe', 'expect', 'intend', 'potential', 'estimate', 'budget', 'scheduled', 'plans', 'planned', 'forecasts', 'goals' and similar expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual financial results, performance or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by those forward-looking statements and the forward-looking statements are not guarantees of future performance. Mogo's growth, its ability to expand into new products and markets and its expectations for its future financial performance are subject to a number of conditions, many of which are outside of Mogo's control. For a description of the risks associated with Mogo's business please refer to the 'Risk Factors' section of Mogo's current annual information form, which is available at and Except as required by law, Mogo disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise. Article content Article content Article content Article content Article content Article content investors@ Article content Article content Article content

Information about TFSA contribution limits now available, says the CRA
Information about TFSA contribution limits now available, says the CRA

CBC

time2 hours ago

  • CBC

Information about TFSA contribution limits now available, says the CRA

The Canada Revenue Agency (CRA) says it has resolved an issue that prevented people from seeing how much contribution room they had left in their tax-free savings accounts (TFSAs). That information first became unavailable on April 17. CRA spokesperson Charles Drouin told CBC News in an email that the federal agency introduced a new data validation process this year to ensure that tax information submitted to them is accurate. "Upfront validations now advise these filers of errors with their information return submission in real-time and prevent the submission of invalid returns," Drouin wrote. He said the new system would ultimately improve the quality of the data the Canada Revenue Agency receives and allow for any errors to be corrected faster. But he added that "stricter validations and new processes caused delays in receiving and processing the information returns. As a result, there have been delays in processing TFSA annual information returns this year." Each year, Canadians 18 or older get more contribution room in their tax-free savings accounts, which shield investments from taxes. In 2025, for example, the new contribution limit was $7,000. If someone was 18 in 2009 – the year the the savings accounts were introduced – has lived in Canada since then and never contributed to their TFSA, their total contribution limit would be $102,000 as of Jan. 1, 2025. If someone didn't properly track their contributions over the years, though, they could risk going over their limit, which comes with a one per cent interest penalty per month for those funds over the limit. The CRA website notes that posted contribution limits do not take into account any contributions to the TFSA made since Jan. 1, 2025.

DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints
DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints

Cision Canada

time3 hours ago

  • Cision Canada

DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Resourcing Constraints

- FDA decision anticipated within four weeks - TORONTO, June 13, 2025 /CNW/ - DRI Healthcare Trust (TSX: (TSX: DHT.U) (the "Trust") today announced KalVista Pharmaceuticals ("KalVista") has disclosed that it has received notice from the U.S. Food and Drug Administration ("FDA") that the FDA will not meet the June 17, 2025 PDUFA goal date for the New Drug Application (NDA) for sebetralstat, due to a heavy workload and agency resourcing issues. KalVista commented that the FDA has not requested additional data or studies and has communicated to KalVista that it anticipates delivering a decision within approximately four weeks. KalVista issued its own press release with the announcement earlier today (link). About DRI Healthcare Trust The Trust is managed by DRI Capital Inc., a pioneer in global pharmaceutical royalty monetization. Since its initial public offering in 2021, the Trust has deployed more than $1.0 billion, acquiring more than 25 royalties on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza, Stelara, Vonjo, Zejula and Zytiga. The Trust's units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol " and in U.S. dollars under the symbol "DHT.U". To learn more, visit or follow us on LinkedIn. SOURCE DRI Healthcare Trust

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store